Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
about
Autologous Cells for Kidney BioengineeringHealth Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated MalignanciesCaerulomycin A suppresses immunity by inhibiting T cell activityAcute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature reviewUltrasonographic features of kidney transplants and their complications: an imaging review.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Cancer in Korean patients with end-stage renal disease: A 7-year follow-upAn effective approach to prevent immune rejection of human ESC-derived allografts.Malignant and noninvasive skin tumours in renal transplant recipientsRoles of the immune system in skin cancer.Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up studyReduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study.Cancer in the transplant recipient.A retrospective analysis of dermatological lesions in kidney transplant patientsInflammatory Cutaneous Diseases in Renal Transplant RecipientsUrothelial carcinoma of donor origin in a kidney transplant patient.Sonographically Unusual Breast Carcinomas, 2 Case Reports.The association of community health indicators with outcomes for kidney transplant recipients in the United States.Cancer-related outcomes in kidney allograft recipients in England versus New York State: a comparative population-cohort analysis between 2003 and 2013.Update on the long-term complications of renal transplantation.The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.Genetics and nonmelanoma skin cancer in kidney transplant recipients.Renal cancer in kidney transplanted patients.Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.Risk Factors for De Novo Malignancy Following Lung Transplantation.Management considerations in the failing renal allograft.Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study.Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantationSynthesis of N-dialkylphosphoryl iminosugar derivatives and their immunosuppressive activities.Safety and efficacy of a novel short occlusive regimen of imiquimod for selected non-melanotic skin lesions in renal transplant patients.The correlation between renal transplantation and liver carcinoma: a meta-analysis.Donor-associated malignancy in kidney transplant patientsTwenty-year survivors of kidney transplantation.Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin.Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone.A new method for classifying different phenotypes of kidney transplantation.
P2860
Q26740036-1C3DE8F3-3DF7-4032-BFDB-E4E5ECB0FB99Q26770541-B8CC857F-6A57-4536-B528-8D94B71E323CQ27348735-44E2FBF7-9B6B-4DC9-BA9B-AB1F9EE5013DQ28074030-9F9D5B22-2C6D-4F02-A5A4-88A21ABA4A23Q30436079-196C26D6-D9C9-43C0-97A5-57ABF32579A7Q33660069-CAE81001-DFE6-47A5-B3D7-A0CC3886F8F2Q33888107-CBB6EDFF-77BD-4EC4-A528-85F4057B2B88Q34039500-A7596B00-64EF-4157-A4A9-75446C4816D9Q34268585-BC627C3C-BEA1-4B97-8DC9-D18E8E7FCDA0Q35403714-801E3C68-4236-4243-8AD8-259C5E9E762CQ35462692-05B4DB64-0803-4BB4-A6FD-BA5CD89B3650Q35690978-2C793E52-5019-45BD-82DA-4C9A329224E7Q36516024-64190A3D-330C-4F9A-8A5A-2FC4B8B8206AQ36740987-BBC5120B-1A26-4D38-9D06-584E5638DF43Q36938488-88FDB545-D32E-43FC-B14A-9B534B6A1339Q37073252-FEA58A2F-417D-4237-ADA1-C36FECC82CA6Q37210249-979104AC-5831-495D-B068-6A74CEAFE9DCQ37346088-FDF86281-D6CC-4E29-8FA2-0F1FEC363491Q37376810-A8ECA66A-AC88-442E-9782-59E9C6A3B9BCQ37432957-87E0C359-2E25-4198-B9C6-839D9A4E6465Q37693392-9B655F7D-F638-443E-AF5F-5165D0CAF014Q38104335-DD02190B-0C3C-48EA-968A-4C75CC7E8648Q38260092-DA57C79D-2FDF-4E76-8668-647470A0D863Q38330222-2A906A24-02BF-494D-9F39-ABC0DC5B34F6Q38552310-80E6211D-36FB-42A5-8892-B47D33345EEAQ38668601-7ED7789F-0086-47FE-B47C-0BBE9AD7A2C6Q38830835-C153F990-8B10-4FFF-9568-7AB6A421CEF1Q39227230-942447D4-B83B-4C33-8EA5-E5F0ECF091BCQ39671599-689905A6-DCDA-45AE-AEBE-0405C354E29EQ40047072-8243FEAB-541B-4B24-A11B-519C59B52D68Q40199766-706352BE-9A4A-4C35-9960-8BC461FE8D54Q40336926-CADEB76F-915B-4D2D-B392-29E39550078BQ40626762-51B5BD64-7414-4740-9423-76FEE896781EQ40858655-ED9AFE25-1EBC-4007-A491-6465E513C939Q41924348-64B69D4F-37CE-42D3-8678-9741EF0B6373Q42572911-7075C39F-771E-4E74-A4D3-623150244469Q45913676-D05AF2BA-709D-4E05-B986-8EA8B19710F0Q47122472-3D30CBA4-CF7C-4B16-B013-A027A2419482Q50019712-2317C6A7-A47D-4B98-A59C-FE65062CAC49Q50630834-739EE57C-E7AD-4F90-8FEB-02C864B93975
P2860
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@ast
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@en
type
label
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@ast
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@en
prefLabel
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@ast
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@en
P2093
P2860
P50
P356
P1476
Long-term cancer risk of immunosuppressive regimens after kidney transplantation.
@en
P2093
Josette Eris
Martin P Gallagher
Patrick J Kelly
P2860
P304
P356
10.1681/ASN.2009101043
P577
2010-04-29T00:00:00Z